covid

Rich countries have received more vaccines in run-up to the holiday season than African countries have all year

December 24, 2021

The EU, UK and US have received more doses in the last six weeks than African countries have received all year.
Global rollout at speed of UK’s booster programme could vaccinate the world by February.
At current rates vaccine manufacturers will fail to deliver enough doses to fully vaccinate everyone in Africa by next holiday period.

More doses of Covid-19 vaccines have been delivered to the EU, the UK and the United States in the six-week run up to the holidays than African countries have received all year, new analysis from the People’s Vaccine Alliance reveals today.

As Covid-19 clouds a second Holiday season in uncertainty and fear in many countries, campaigners warn that governments risk trapping the world in an endless cycle of variants, boosters, restrictions and even lockdowns, if low vaccination rates are allowed to persist in the global south.

Low and middle-income countries must be allowed to manufacture vaccines themselves to end vaccine inequality and prevent variants from derailing future holiday seasons, campaigners warn.

Between 11 November and 21 December 2021, the EU, UK and US have received 513 million doses of vaccines while countries in Africa received just 500 million throughout the whole of 2021.

The UK government, facing a rapid surge in Omicron variant, has a target of administering one million booster doses of Covid-19 vaccines a day in response, equivalent to vaccinating 1.46 percent of the population every day. If every country was able to vaccinate at the same rate as the UK target, it would take just 68 days to deliver a first dose to everyone who needs one, leaving no one unvaccinated by the end of February 2022.

Just 8.6 percent of people in Africa have been fully vaccinated to date and at the current rate of delivery by vaccine manufacturers, it won’t be until April 2023 that everyone will receive their first dose. Recent research found that 78 percent of people in Africa are willing to get vaccinated, higher than in many rich countries.

G7 countries will have 1.4 billion surplus doses by March 2022, even after giving all adults a booster but are failing to deliver on donation pledges. The US has delivered just a quarter of the vaccines it promised to donate while the UK and Germany have delivered 15 percent and 14 percent respectively.

Anna Marriott, Health Policy Manager, Oxfam and the People’s Vaccine Alliance, said:

“Make no mistake rich country governments are to blame for the uncertainty and fear that is once again clouding the holiday season. By blocking the real solutions to vaccine access in poorer countries they are prolonging the pandemic and all its suffering for every one of us.

“Rich countries are banking on boosters to keep them safe from Omicron and future variants of Covid-19. But boosters can never be more than a temporary and inadequate firewall. Extinguishing the threat of variants and ending this pandemic requires vaccinating the world. And that means sharing vaccine recipes and letting developing countries manufacture jabs for themselves.”

Experts have raised concerns that low vaccine coverage in the global south created conditions where a variant like Omicron was likely to emerge. Nine months ago, a survey of leading epidemiologists warned that persistent low vaccine coverage in parts of the world increased the risk of vaccine resistant variants emerging within a year or less.

Nick Dearden, Director of Global Justice Now, said:

“If we ever want to have a normal Christmas again, we need to vaccinate the world. But right now, the UK and EU are holding back international efforts to use and expand manufacturing and distribution capacity in low and middle-income countries. It’s reckless and risks trapping us in an endless cycle of variants, boosters, restrictions and even lockdowns.”

In October 2020, India and South Africa proposed a waiver of intellectual property rules on Covid-19 vaccines, tests and treatments to allow low and middle-income countries to manufacture these life-saving tools. Despite most countries, including the United States, supporting a waiver, the UK, EU, and Switzerland have prevented progress.

Maaza Seyoum from the African Alliance said:

“Leaders in the global north have so far chosen the obscene profits of pharmaceutical companies over the lives of people in Africa. But the Omicron variant shows that vaccine inequality is a threat to everyone, everywhere. Boris Johnson, Olaf Scholz, and European leaders need to finally support an intellectual property waiver and let Africa and the global south unlock its capacity to manufacture and distribute vaccines. Otherwise, humanity will never beat the race against the next variant.”

Human Rights Watch and Médecins Sans Frontières identified over 100 manufacturers that could produce mRNA vaccines if intellectual property barriers were removed and pharmaceutical companies transferred the technology and knowhow needed.

Despite already making billions in profit, Pfizer and Moderna continue to refuse to share the new generation of vaccine technology with the WHO’s mRNA hub in South Africa. WHO scientists are now attempting to reverse engineer Moderna’s US-taxpayer-funded vaccine, a process that could take two years longer than if the company shared its vaccine recipe.

Every major vaccine provider has boycotted the WHO’s Covid-19 technology access pool (C-TAP), a technology transfer programme established in May 2020 to share the recipe and knowhow needed to manufacture coronavirus vaccines, tests and treatments.

In a video marking World Aids Day, Prince Harry called on governments to break vaccine monopolies, joining over 170 former world leaders and Nobel Laureates, the Pope and more than 13 million people in their support for the waiver.

Notes

Data on delivery from Airfinity, analysed by People’s Vaccine Alliance.
In total the EU and UK and US have received over 2 billion vaccine doses, including boosters, as well as first and second doses.
Our World in Data was used to calculate how many doses were needed to vaccinate people in Africa.
Over the last 40 days, African countries are receiving on average enough doses to fully vaccinate 3 million a day (fully vaccinates is 1 dose of Johnson & Johnson and 2 doses for all other vaccines). At this rate, it will take 438 days for everyone currently unvaccinated in Africa to be fully vaccinated.
While rich countries have cut bilateral deals with pharmaceutical companies to secure dose, poorer countries have depended on Covax, the multilateral mechanism for equitably distributing Covid-19 vaccines, which has repeatedly cut delivery forecasts, as well as a trickle of donations from wealthy countries which are often close to their expiry dates.
Numbers of doses donated by rich countries https://www.ifpma.org/wp-content/uploads/2021/12/Airfinity_COVID-19_Intel_Report_16December2021.pdf page 7
Pharmaceutical monopolies will net Pfizer, BioNTech and Moderna $34 billion this year in pre-tax profits.

Failure to vaccinate the world created perfect breeding ground for Omicron, say campaigners

December 6, 2021

Campaigners from the People’s Vaccine Alliance say the refusal of pharmaceutical companies to openly share their vaccine science and technology and the lack of action from rich countries to ensure access to vaccines globally have created the perfect breeding ground for new variants such as Omicron.

A year since a UK grandmother became the first person in the world to receive the Pfizer/BioNTech COVID-19 vaccine, great strides have been made to fully vaccinate over three billion people, but many poorer parts of the world have been left behind. While countries like the UK and Canada have had enough doses to fully vaccinate their entire populations, Sub-Saharan Africa has only received enough doses to vaccinate 1 in 8 people. The number of people in the UK who’ve had their third booster jab is almost the same as the total number of people fully vaccinated across all of the world’s poorest countries.

The People’s Vaccine Alliance, which has over 80 members including the African Alliance, Oxfam and UNAIDS, are calling for pharmaceutical firms and rich nations to change course before it is too late. This must include:

Immediate approval of the waiving of intellectual property rules to end the monopoly control of pharmaceutical firms over COVID-19 vaccines, tests and treatments. The World Trade Organization (WHO) General Council must urgently reconvene now, not next year, to finally get a waiver agreed.
All vaccines including new versions of vaccines designed to combat the Omicron variant to be declared global public goods, and vaccine recipes and know-how shared openly with producers worldwide via the WHO.

Winnie Byanyima, Executive Director of UNAIDS and Co-Chair of the People’s Vaccine Alliance, said: “Omicron is with us because we have failed to vaccinate the world. This should be a wake-up call.

“Business as usual has led to huge profits for pharmaceutical firms, but many people left unvaccinated meaning that this virus continues to mutate. It is the definition of madness to keep doing the same thing and expect a different outcome. We need to press reset.

“We call on Pfizer, Moderna, BioNTech and others to change course. You have made huge profits in the last year. We now have vaccine billionaires. You don’t need to make any more money. Changing your vaccines to meet the challenge of Omicron is no good if your vaccine recipes are once again locked up behind a wall of profit and monopoly.”

The Alliance are also calling on rich nations to change course by using all their powers to insist on the open sharing of successful vaccine technology and know-how and to fund a huge expansion in vaccine production all over the world.

Back in March, the Alliance along with 77 epidemiologists from some of the world’s leading academic institutions warned that unless we vaccinate the world, we’d be at risk of virus mutations that could render our current vaccines ineffective.

Maaza Seyoum, of the African Alliance and People’s Vaccine Alliance Africa, said: “Fighting to buy up limited supplies of hugely expensive vaccines to protect your own citizens whilst ignoring the rest of the world will only lead to more variants, more mutations, more lockdowns and more lives lost. The same leaders, after failing the world repeatedly while allowing profiteering, are now laying the blame at the doorstep of the countries they have ignored.

“Pharmaceutical monopolies and profiteering have prevented vaccination in Africa and the rest of the developing world. It is time that pharmaceutical companies and rich nations finally put protecting people and putting an end to this pandemic ahead of profits, monopolies and self-defeating attempts to protect themselves whilst allowing this disease to rampage across the rest of the world.”

Oxfam’s Health Policy Manager Anna Marriott said: “With the new threat of the Omicron variant, it is clear that we cannot just booster our way out of the pandemic while leaving much of the developing world behind. Unless all countries are vaccinated as soon as possible we could see wave after wave of variants.

“What is the point in developing new vaccines in 100 days if they are then only sold in limited amounts to the highest bidder, once again leaving poor nations at the back of the queue?

“We cannot correct the mistakes of the past 21 months but we need rich countries to chart a new path forward in which they step up and insist the pharmaceutical companies start sharing their science and technology with qualified manufacturers around the world, so we can vaccinate people in all countries and finally end the pandemic.”

In a statement sent to European Union negotiators and member states this week, the People’s Vaccine Alliance joined with more than 170 charities, NGOs, unions and campaign groups – including ONE campaign and the International Union of Food Workers – in criticising the EU’s opposition to a waiver of intellectual property rules. The statement said that “the identification of the Omicron variant only heightens the urgency of a change in approach and is evidence of why the EU’s position is a threat to us all”.

Last week Norway was the latest of more than 100 countries to offer their support for the waiver. Meanwhile President Emmanuel Macron withdraw France’s earlier support, a decision the Alliance has called ludicrous and dangerous in the face of the new variant.

John Mark Mwanika, ITF Urban Transport Chair, Uganda, said: “It’s not only shameful that six times more booster shots are being administered daily than primary doses in low-income countries, it’s an enormous risk to ending the pandemic globally.

“It is no coincidence that the new Omicron variant was first discovered by scientists in countries which have been denied the right to produce their own vaccines. We are in a global emergency and workers are paying the price, particularly in the Global South.”

The People’s Vaccine Alliance has created a virtual memorial wall to honour and remember those who have lost their lives to COVID-19, and to demand that leaders act to prevent more deaths.

Notes to editors:

The People’s Vaccine Alliance has created a virtual memorial wall will be revealed at peoplesvaccine.org/memorial-wall on 8 December, marking a year since the first vaccine was administered.
Sub-Saharan Africa countries have received enough doses to fully vaccinate 136,765,144 people, 12.8 per cent of the total population or 1 in 8, according to Airfinity data analysed by the People’s Vaccine Alliance.
Figures for how many vaccines the UK and other Western countries have received are from Airfinity.
According to Our World in Data 9 million people in Low Income Countries are fully vaccinated. As of 2 December, the UK had administered booster doses to just over 19 million people, according to: https://coronavirus.data.gov.uk/details/vaccinations
Information on the survey of epidemiologists carried out by the People’s Vaccine Alliance in March available here.
The full statement to the EU and list of signatories is available here.

World Trade Organisation talks on vaccines postponed due to concerns over the spread of a new variant of COVID-19

November 30, 2021

Responding to the announcement that World Trade Organisation talks on vaccines due to take place in Geneva next week have been postponed due to concerns over the spread of a new variant of COVID-19 which has emerged in South Africa, People’s Vaccine Alliance spokesperson and Oxfam health Policy Manager, Anna Marriott, said:

“The vaccine apartheid that rich countries and the World Trade Organisation have refused to address is ultimately responsible for the decision to postpone these talks.

“It should be a stain on the conscience of those who have blocked the waiver of Intellectual Property that South Africa is now facing the threat of a dangerous new virus variant with less than a quarter of its population fully vaccinated, especially given the fact the country has been so vocal in calling for the waiver which would allow more vaccines to be produced globally.

“There can be no more delays, putting pharmaceutical profits before people’s lives is clearly a risk to us all. We do not need a ministerial summit to agree to this, we just need governments to put the good of humanity above the profits of a handful of companies.”

The Ignored Pandemic Report

November 25, 2021

A new Oxfam report shows an undeniable increase in gender-based violence (GBV) during the COVID-19 pandemic around the world to which too many governments and donors are not doing enough to tackle.

The report, The Ignored Pandemic: The Dual Crisis of Gender-Based Violence and COVID-19, showed the number of calls made by survivors to domestic violence hotlines in ten countries during the first months of lockdown. The data reveals a 25 – 111 percentage surge; in Argentina (25%), Colombia (79%), Tunisia (43%), China (50%), Somalia (50%), South Africa (69%), UK (25%), Cyprus (39%), Italy (73%) and the largest increase in Malaysia where calls surged by over 111%.

In many households, coronavirus has created a ‘perfect storm’ of social and personal anxiety, stress, economic pressure, social isolation, including with abusive family members or partners, and rising alcohol and substance use, resulting in increases in domestic abuse.

Meanwhile, India too recorded an increase of 250 percent of domestic violence cases, according to the National Commission for Women. Domestic violence counselors there reported being unable to reach women and girls who were grievously injured or suicidal or those whose partners controlled their access to phones.

The report shows that not enough countries have acted with sufficient seriousness to tackle the GBV pandemic. Even before the surge in GBV cases sparked by the pandemic, in 2018 alone, over 245 million women and girls were subjected to sexual or physical violence by an intimate partner – a greater number than the global total of coronavirus cases (199m) between October 2020 and October 2021.

“It is a scandal that millions of women and girls, and LGBTQIA+ people have to live through this double pandemic of violence and COVID-19. GBV has led to injuries, emotional distress, and increasing poverty and suffering, all of which are utterly inexcusable and avoidable. The pandemic has exposed the systematic failure of governments around the world to protect women and girls and LGBTQIA+ people from violence against them – simply because of who they are,” said Oxfam International Executive Director Gabriela Bucher.

Women’s rights organisations whose mission is to support women and girls and LGBTQIA+ people from violence have been more likely to have been hit by funding cuts, exactly at the time when their work is most needed. In an Oxfam survey published in June this year, over 200 women’s rights organisations across 38 countries reported reduced funding and shrinking access to decision-making spaces. Thirty-three percent had to lay off between one to ten staff, while nine percent had to close altogether.

Even though 146 UN member states have formally declared their support for action against GBV in their COVID-19 response and recovery plans, only a handful have followed through. Of the $26.7 trillion that governments and donors mobilised to respond to the pandemic in 2020, just 0.0002% has gone into combating GBV.

“The pandemic has worsened long-standing gender discriminations, and this has increased the vulnerability of women and girls and LGBTQIA+ people to violence and abuse. If governments do not deliberately initiate strong, properly funded strategies to tackle this, the gains made in women’s empowerment in the last 30 years are at risk. We need to avert this, and the time is now,” said Bucher.

A few governments, however, have made efforts to respond to the GBV crisis. For instance, Indonesia and New Zealand introduced national protocols and identified GBV service providers as essential workers. South Africa took steps to strengthen GBV reporting channels.

The 16 Days of Activism against Gender-Based Violence that commences today until 10 December 2021 provides an opportunity for governments, donors, and activists to reflect on the emerging issues of inequality that put women and girls at risk and address them urgently. The COVID-19 pandemic has shown that governments can take extraordinary measures to protect their citizens and respond to deadly crises when spurred to action. We need to see more efforts to tackle gender-based violence.

Oxfam recommends that states and governments ensure a more coordinated, comprehensive, and multi-sectoral GBV response that enables survivors to access effective and quality services. Governments and donors should channel more funding to women’s rights organisations and feminist movements working to end GBV and support survivors. Additionally, more funding should be allocated to better data collection and analysis of gender-disaggregated national statistics to inform evidence-based interventions to end GBV.

“As the world comes together to mark 30 years of the 16 Days of Activism against Gender-Based Violence, there is an urgent need for a truly gendered approach in every country’s effort to respond to and recover from COVID-19. Governments and donors need to live up to their commitments to promote gender equality by ensuring investment in all the areas we know could help end GBV. Only by doing so can we strive for a future that is more just, safe, and in which people live free from discrimination,” said Bucher.

Notes:

The 16 Days of Activism against Gender-Based Violence is an annual international event that runs for 16 days from 25^th November, the International Day for the Elimination of violence against women, until 10^th December, Human Rights Day. This year’s event marks 30 years since its first commemoration in 1991. The event is a platform used by organisations and activists globally to call for the prevention and elimination of violence against women and girls.

The data on calls to domestic/GBV helplines in ten low, middle- and high-income countries during the first wave of the COVID-19 pandemic has been compiled from different UN, national and international NGO reports and government sources. The increase in call volumes is presented as a range between the lowest and highest percentage value among the different countries.

For more information or an interview, contact:

Florence Ogola, in Nairobi [email protected] +254 733770522

Read the report: https://policy-practice.oxfam.org/publications/the-ignored-pandemic-the-dual-crises-of-gender-based-violence-and-covid-19-621309

Pfizer, BioNTech and Moderna making US$1,000 profit every second while world’s poorest countries remain largely unvaccinated

November 16, 2021

Demand grows for firms to share vaccine recipes and technology as billionaire pharma bosses convene for ‘Big Pharma Davos’

New figures from the Peoples Vaccine Alliance reveal that the companies behind two of the most successful COVID vaccines – Pfizer, BioNTech and Moderna – are making combined profits of US$65,000 (NZ$92,000) every minute. The figures based on the latest company reports are released as CEOs from pharmaceutical industry meet for the annual STAT summit – the equivalent of a ‘Big Pharma Davos’ – from 16 – 18 November.

These companies have sold the majority of doses to rich countries, leaving low income countries out in the cold. Pfizer and BioNTech have delivered less than one percent of their total vaccine supplies to low-income countries, while Moderna has delivered just 0.2 percent. Meanwhile 98 percent of people in low income countries have not been fully vaccinated.

Maaza Seyoum of the African Alliance and People’s Vaccine Alliance Africa said: “It is obscene that just a few companies are making millions of dollars in profit every single hour, while just two percent of people in low-income countries have been fully vaccinated against coronavirus.

“Pfizer, BioNTech and Moderna have used their monopolies to prioritise the most profitable contracts with the richest governments, leaving low income countries out in the cold.”

Despite receiving public funding of over US$8 billion, the three corporations have refused calls to urgently transfer vaccine technology and know-how with capable producers in low- and middle-income countries via the World Health Organisation (WHO), a move that could increase global supply, drive down prices and save millions of lives. In Moderna’s case, this is despite explicit pressure from the White House and requests from the WHO that the company collaborate in and help accelerate its plan to replicate the Moderna vaccine for wider production at its mRNA hub in South Africa.

While Albert Bourla, the CEO of Pfizer, described the call to share vaccine recipes ‘dangerous nonsense,’ the WHO emergency use approval of the Indian vaccine Covaxin earlier this month is clear evidence that developing countries have the capacity and expertise.

Anna Marriott, Oxfam’s Health Policy Manager said: “Contrary to what Pfizer’s CEO says, the real nonsense is claiming the experience and expertise to develop and manufacture life-saving medicines and vaccines does not exist in developing countries. This is just a false excuse that pharmaceutical companies are hiding behind to protect their astronomical profits.

“It is also a complete failure of government to allow these companies to maintain monopoly control and artificially constrain supply in the midst of a pandemic while so many people in the world are yet to be vaccinated.”

Based on company financial statements, the Alliance estimates that Pfizer, BioNTech and Moderna will make pre-tax profits of US$34 billion this year between them, which works out as over a thousand dollars a second, US$65,000 a minute or US$93.5 million a day. The monopolies these companies hold have produced five new billionaires during the pandemic, with a combined net wealth of US$35.1 billion.

The People’s Vaccine Alliance, which has 80 members including the African Alliance, Global Justice Now, Oxfam, and UNAIDS, is calling for the pharmaceutical corporations to immediately suspend intellectual property rights for COVID vaccines, tests, treatments, and other medical tools by agreeing to the proposed waiver of the TRIPS Agreement at the World Trade Organisation.

They are also calling on governments, including the United States, to use all their legal and policy tools to demand that pharmaceutical companies share COVID-19 data, know-how, and technology with the WHO’s COVID-19 Technology Access Pool and South Africa mRNA Technology Transfer Hub.

More than 100 nations, led by South Africa and India – with the support of the US – have been calling for the TRIPS waiver, which also has the support of over 100 past and present world leaders and Nobel laureates.

Despite this, other rich nations, including the UK and Germany, are still blocking the proposal, putting the interest of pharmaceutical companies over what’s best for the world. This issue is set to dominate the World Trade Organisation Ministerial Summit to be held in Geneva from 30 November to 3 December.

Notes to editors:

A People’s Vaccine Alliance report from 21 October found that Moderna has only delivered 0.2 percent of their total vaccine supply to low-income countries and Pfizer/BioNTech has delivered less than 1
In their Q3 financial statement, Pfizer forecast US$36bn in vaccine revenue for 2021. Gross profit from the revenue is split 50/50 with BioNTech. Pfizer guidance for their income before tax (after splitting profit with BioNTech) is ‘High-20s as a Percentage of Revenues.’ A conservative 25% margin would bring Pfizer’s profit before tax to US$9bn in 2021 from the Comirnaty Covid vaccine.
In BioNTech’s Q3 financial statement they forecast €16-17 billion in vaccine revenue for 2021. In the 9 months ending September 30 the company made € 10.3bn profit before tax on €13.4bn, revenue giving a 77% profit margin. Using a conservative €16bn forecasted revenue for the full year, we therefore estimate that at a 77% profit margin, BioNTech will make €12.3bn in pre-tax profit in 2021 – or US$14.7bn using the 2021 average exchange rate.
Moderna’s Q3 profit before tax for 9 months ending September 30 is US$7.8bn on US$11.2bn revenue giving a pre-tax profit margin of 70%. The company projects full year 2021 sales to be “between US$15 billion and US$18 billion”. Using the lower end of the estimate – 70% of US$15bn is US$10.5bn in profit for 2021. The vaccine is Moderna’s only commercial product.
We therefore estimate the combined 2021 profit before tax for Moderna and Pfizer and BioNTech as US$34bn. There are 525600 minutes in a year giving US$ 64,961 profit before tax per minute or US$1,083 per second. Pre-tax, rather than net, profit is used as Pfizer only report the guidance for pre-tax profit margin.
One New Zealand dollar is worth approximately 70 US cents.

Oxfam: New Zealand must do more for PNG – urgently

November 16, 2021

Papua New Guinea faces a deadly pandemic of misinformation

In response to the New Zealand government sending a medical and logistics support team to Papua New Guinea (PNG) over the weekend, Oxfam Aotearoa says that while essential supplies and support is a good contribution, the government can, and must, do more.

Oxfam Aotearoa Communications and Advocacy Director Dr Jo Spratt said:

“Recently, we heard Hon. Minister Mahuta outline how Aotearoa would partner with Pacific countries to achieve resilience. Referring to our Pacific neighbours as family, the Minister recognised our deep and enduring whakapapa connections – Tātai Hono, and reiterated the importance of Tātou Tātou – all of us together. If there is any time to put these values into action, it is when one of our family members is experiencing a severe humanitarian crisis. This support from the government is a good start, but more needs to be done and urgently.”

Oxfam Papua New Guinea Country Director Eunice Wotene says that as the third coronavirus wave escalates out of control in the country, people are experiencing a lot of challenges. There are multiple issues over Covid-19 vaccinations, lockdowns, and an overwhelmed health system further perpetuating an already stressful situation.

In an effort to control the outbreak, the PNG government has put in place control measures banning gatherings of more than 20 people and encouraging the general public to follow the “Niupela Pasin” (new normal). Provincial Controllers like that of the Eastern Highland Province have implemented travel restrictions across the borders between districts. Wotene says that control measures implemented at the provincial level have helped reduce the spread of infection and has resulted in a reduction in the number of cases presenting at the hospital. However, this has also caused challenges and restricted people from getting to vaccination centres. It has also created economic challenges for people because they can’t get to markets, sell their produce, and earn an income to sustain themselves. This has, in turn, led to an increase in other social issues like petty crimes.

Thousands of doses of the AstraZeneca and Johnson & Johnson vaccines have been coming into PNG from neighbouring countries, but despite the large number of vaccines, PNG is struggling to get its vaccination rates above 9 per cent. Wotene says that while vaccines are welcome and needed, people are either misinformed about the risks, or unable to get vaccines:

“The situation is complicated. Many of our people live in remote rural villages. Information and vaccines aren’t reaching them, and travel restrictions between district borders make things difficult. For some people, even if they could make it to a clinic, they aren’t going because of the misinformation out there about the vaccines’ side-effects. There is a real sense of urgency now that we must do all we can to reach these people.

“In some villages, two or more family members have died from Covid-19, just days or weeks apart. We have a health system overcome with sick people and our people are dying.”

Local and international media recently reported that due to Port Moresby morgues being overwhelmed with the dead, PNG authorities had no choice but to approve mass burial.

New World Bank research, titled Addressing Vaccine Hesitancy: Survey and Experimental Evidence from Papua New Guinea, examined the motivation behind vaccine hesitancy in Papua New Guinea and tested various means of increasing people’s willingness to receive a Covid-19 vaccine. The report found that one of the main hurdles for Papua New Guineans was the fear of the vaccine itself. However, people’s replies also indicated they were open to learning more, particularly if information came from health workers. The research showed that when people were given basic information on the safety of the vaccine and the dangers of Covid-19 that increased the percentage of people who said they were willing to be vaccinated.

Wotene said: “We need health workers to go to the people to provide useful and factual information and help ease their fears. There is also need for mobile clinics where people from the rural communities can be reached for vaccination.”

Dr Spratt said: “In addition to the recent support and supplies, the NZ government should send new emergency funding to support the PNG government and other development partners to rapidly roll-out vaccine information campaigns across the country. This could be done through village health workers, local radio stations and other locally-appropriate communication methods.

“New Zealand still has millions of spare AstraZeneca and Janssen vaccines that we are not using here. We can and should donate these to PNG.”

Ends

Notes:

See the full report Addressing Vaccine Hesitancy: Survey and Experimental Evidence from Papua New Guinea